Jan 20, 2026 | staff reporterSave for later NEW YORK — UK nonprofit research organization LifeArc said on Monday that it has partnered with the Global Alzheimer’s Platform Foundation (GAP) to evaluate a blood-based test for Alzheimer’s disease. The test is designed to detect three proteins — phosphorylated tau 217, glial fibrillary acidic protein, and neurofilament light […]
Washington D.C., Jan 20, 2026, The Global Alzheimer’s Platform Foundation® (GAP) applauds the House and Senate Committees on appropriations releasing their final bipartisan FY2026 Labor–Health and Human Services–Education appropriations bill which increases funding for Alzheimer’s disease and other dementia research. “Congress’s bipartisan approval of increased funding for neurodegenerative research sends a powerful message to the millions of […]
The test aims to pick up three proteins known to be associated with Alzheimer’s Jane KirbyMonday 19 January 2026 11:14 GMT Bookmark popover Removed from bookmarksClose popover A pioneering trial has begun to assess whether a simple finger-prick blood test could offer an early diagnosis for Alzheimer’s disease, even before symptoms manifest. Experts are optimistic […]
A major international research project is underway to test whether a finger prick-style blood test could be used to help diagnose Alzheimer’s disease. The trial is looking at three proteins in the blood that are associated with Alzheimer’s and comparing this with the current gold standard approach to diagnosing the disease that uses expensive brain […]
By Jacquelyn Voghel 01/18/2026 EAST PROVIDENCE – A national research institution’s Rhode Island location is calling for volunteers with Alzheimer’s disease to participate in a study attempting to identify predictive markers of the brain condition. K2 Medical Research – East Providence has begun enrolling participants in the Bio-Hermes 002 Study, an initiative of the Global Alzheimer’s Platform Foundation. The study seeks […]
Spear Bio joins collaborative study focused on new biomarkers designed to improvediagnosis of Alzheimer’s disease and dementias Washington D.C., Jan 12, 2026 – The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Spear Bio, a biotechnology company pioneering wash-free ultrasensitive immunoassay technology, to the Bio-Hermes-002 study. This collaboration will enhance this unique, observational platform […]
Washington D.C., Jan 9, 2026 – The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, to the Bio-Hermes studies. This collaboration will enhance the unique, observational platform studies that compare blood-based and digital biomarkers across a broad range of clinical […]
Collaboration to Improve Access to Study for Alzheimer’s Disease Las Vegas, Nev. – Dec. 23 2025 – Today, Global Alzheimer’s Platform Foundation® (GAP) and Clinical Neurology Specialists (CNS) announced their collaboration to accelerate Alzheimer’s disease research in Las Vegas. CNS has joined the GAP-sponsored study, Bio-Hermes-002, a unique, observational platform study that compares blood-based and digital biomarkers […]
20 Dec ‘It’s the best time’: Family members may notice signs of Alzheimer’s at holiday gatherings Posted at 20:23h in Uncategorized by Belinda Russell 0 Comments ATLANTIS, Fla. — It’s the holiday season and while you celebrate with friends and family some experts say you may also notice some changes in elderly loved ones you haven’t seen for a while. Dr. Linda […]
Aging Emerging biomarkers and digital tools are unlocking earlier and more accurate diagnosis Teresa, 75, an Alzheimer’s patient and former businesswoman, poses for a photograph inside the Alzheimer Foundation, in Mexico City, Mexico, on April 19, 2012.REUTERS/Edgard Garrido by Lydia Wu, Jennifer Panlilio, Melissa Lee, Laura Nisenbaum, Aishu Sukumar December 10, 2025 Alzheimer’s disease and related dementias affect more than […]
The Global Alzheimer’s Platform Foundation® (GAP) today issued a statement following the release of top-line updates from two Alzheimer’s clinical trials: Recently, developments in two important Alzheimer’s clinical research studies were reported. The two studies were: Novo Nordisk’s Phase 3 EVOKE and EVOKE+ trials evaluating oral semaglutide, and Johnson & Johnson’s Phase 2b trial evaluating the […]
About This Episode The quest to speed up clinical trials is personal for John Dwyer, CEO of the Global Alzheimer’s Platform (GAP). A long-time UsA2 advocate, he’s been motivated by the generations of family members lost to Alzheimer’s and Parkinson’s disease. Dwyer shares with BrainStorm host Meryl Comer the critical challenges of NIH funding cuts […]
November 19, 2025 Delivers Life-Changing Early Detection for 580,000 Floridians Living with Alzheimer’s WASHINGTON — Today, Congressman Vern Buchanan, Vice Chairman of the House Ways and Means Committee and Chair of the Health Subcommittee, announced the introduction of the Alzheimer’s Screening and Prevention (ASAP) Act alongside Congressman Paul Tonko (D-N.Y.). Senators Susan Collins (R-Maine) and Catherine Cortez Masto (D-Nev.) introduced companion legislation in the Senate. This bipartisan, bicameral […]
IMPERIAL COUNTY, Calif. (KYMA) – The Sun Valley Research Center (SVRC) is taking a Mobile Research Unit on the road to hold free memory assessments. According to a press release, THOR (Taking Health on the Road) West is touring California and Arizona in order to help raise awareness of the importance of brain health.According to […]
How the U.S. can drive progress into the next era of Alzheimer’s disease careSponsored by Lilly Today, over 7 million Americans are living with Alzheimer’s disease — a number that is expected to more than double by 2060, according to the Alzheimer’s Association. The stakes for the U.S. health care system have never been higher. A […]
International non-profit Global Alzheimer’s Platform Foundation expands research network in California to improve access to research opportunities Washington D.C.- Global Alzheimer’s Platform Foundation® (GAP) announced in a recent press release the addition of Sun Valley Research Center (SVRC) a private clinical research organization based in Imperial, California, to its global network of over 100 best-in-class research sites. SVRC addresses the critical […]
International non-profit Global Alzheimer’s Platform Foundation expands research network in California to improve access to research opportunities Washington D.C., Oct. 14, 2025- Global Alzheimer’s Platform Foundation® (GAP) announces the addition of Sun Valley Research Center (SVRC) a private clinical research organization based in Imperial, California, to its global network of over 100 best-in-class research sites. SVRC […]
Posted on October 2, 2025 • by Julia Ferrar Most biomarker tests, such as PET scans and spinal taps, are expensive or invasive and can pose risks for patients. That’s why a company in the Tampa Bay area is helping to research blood tests for biomarkers as a less expensive and more accessible alternative. Axiom […]
FOX 13’s Allie Corey and her guest discuss Alzheimer’s and the latest research in the disease. Watch the interview with Dr. Steen of Axiom Brain Health here: https://www.fox13news.com/video/1715786
Prevent cognitive decline with these proven lifestyle changes! Join us on PSI TV as Dr. Susan Steen, MD, a renowned neurologist and Alzheimer’s expert, shares groundbreaking insights into brain health. Representing Axiom Brain Health, Dr. Steen discusses their mission to combat neurodegenerative diseases like Alzheimer’s and Parkinson’s through cutting-edge research and clinical trials. Learn how […]
Researchers at Emory Goizueta Brain Health Institute and partner institutions have found new clues in the blood that could help explain why Alzheimer’s disease develops and how it affects memory. The study, published in Nature Aging, examined blood samples from more than 2,100 individuals across four large research cohorts. Using advanced tools, scientists measured thousands of proteins in […]
Story by Ronna Charles • 2 min read Researchers at Emory Goizueta Brain Health Institute and partner institutions have found new clues in the blood that could help explain why Alzheimer’s disease develops and how it affects memory.The study, published in Nature Aging, examined blood samples from more than 2,100 individuals across four large research cohorts. […]
trialsitenews, Aug. 28, 2025, 12:30 p.m. September is Alzheimer’s Awareness Month, a time to reflect on the devastating impact of Alzheimer’s disease and the urgent need for better treatments and care. More than 6 million Americans are living with Alzheimer’s, a number expected to climb steeply in the coming decades. As the need grows, so […]
22 Aug 2025 The current Alzheimer’s disease therapeutic antibodies carry a sizable risk of ARIA, especially for APOE4 carriers. Researchers believe the future of amyloid immunotherapies lies in targeted brain delivery that bypasses the larger blood vessels prone to this side effect, and several companies are working on this. At the Alzheimer’s Association International Conference, […]